7951 - 7975 of 8620 Results
Title
Year
-
OPENTitle: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03914-7Best OA location URL: https://doi.org/10.1186/s12883-024-03914-7Citation Count: 1
-
OPENTitle: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 89Issue #: 19Start Page: 1959End Page: 1969Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000004609Best OA location URL: https://n.neurology.org/content/neurology/89/19/1959.full.pdfCitation Count: 145
-
OPENTitle: Money without collaboration won't bring curesJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 19Issue #: 2Start Page: 127End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nm0213-127Best OA location URL: https://www.nature.com/articles/nm0213-127.pdfCitation Count: 4
-
OPENTitle: Parkinson's Disease Biomarkers: Resources for Discovery and ValidationJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 1Start Page: 241End Page: 242Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2013.246Best OA location URL: https://www.nature.com/articles/npp2013246.pdfCitation Count: 6
- The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results2015OPENTitle: The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary resultsJournal Name: Journal of Translational MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12967-015-0704-9Best OA location URL: https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-015-0704-9Citation Count: 89
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 67
- Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol2016OPENTitle: Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study ProtocolJournal Name: JMIR Research ProtocolsPublisher: JMIR Publications Inc.Vol: 5Issue #: 3Start Page: e172End Page: e172Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/resprot.5990Best OA location URL: https://www.researchprotocols.org/2016/3/e172/PDFCitation Count: 64
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021OPENTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.36866/pn.123.32Best OA location URL: https://static.physoc.org/app/uploads/2021/09/29101854/PN123_2709_WEB_FINAL.pdfCitation Count: 0
- Long read sequencing reveals transgene concatemerization and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotes2025OPENTitle: Long read sequencing reveals transgene concatemerization and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotesJournal Name: Frontiers in Genome EditingPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fgeed.2025.1582097Best OA location URL: https://www.frontiersin.org/journals/genome-editing/articles/10.3389/fgeed.2025.1582097/pdfCitation Count: 0
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study2011OPENTitle: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 10Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2Best OA location URL: http://www.thelancet.com/article/S1474442211701752/pdfCitation Count: 316
-
RESTRICTEDTitle: Suppression of Pain Sensation Caused by Millimeter WavesJournal Name: Anesthesia & AnalgesiaPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 4Start Page: 836End Page: 840Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1213/00000539-199904000-00029Citation Count: 33
-
OPENTitle: Phenotypic characterization of recessive gene knockout rat models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 70Issue #:Start Page: 190End Page: 203Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1016/j.nbd.2014.06.009Best OA location URL: https://doi.org/10.1016/j.nbd.2014.06.009Citation Count: 212
-
OPENTitle: 4319 Team Science in Parkinson’s Research: Connecting Clinicians and Computational TeamsJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 118End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.359Citation Count: 0
-
RESTRICTEDTitle: Fox Trial Finder, un nouvel outil pour la recherche cliniqueJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 170Issue #:Start Page: A133End Page: A134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360Citation Count: 0
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding2019OPENTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 35Issue #:Start Page: 42End Page: 47.e1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8074509Citation Count: 11
-
OPENTitle: Childhood Stiff-Person Syndrome Improved with RituximabJournal Name: Case Reports in NeurologyPublisher: S. Karger AGVol: 4Issue #: 2Start Page: 92End Page: 96Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000339446Best OA location URL: https://www.karger.com/Article/Pdf/339446Citation Count: 46
-
RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 45
- Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study2019OPENTitle: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 71End Page: 80Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133485Citation Count: 120
- Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs2013OPENTitle: Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral OrgansJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 11Start Page: e80705End Page: e80705Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0080705Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0080705&type=printableCitation Count: 180
-
OPENTitle: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In VivoJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 148Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/59758-vBest OA location URL: https://www.jove.com/pdf/59758/generation-alpha-synuclein-preformed-fibrils-from-monomers-useCitation Count: 33
- Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils2017OPENTitle: Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophilsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 1Start Page: 23End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20170803Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/1/23/694098/bcj-2017-0803.pdfCitation Count: 158
-
OPENTitle: Impact of motor fluctuations on real-life gait in Parkinson’s patientsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 62Issue #:Start Page: 388End Page: 394Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.03.045Best OA location URL: https://publications.aston.ac.uk/id/eprint/33121/1/1_s2.0_S0966636218302832_main.pdfCitation Count: 30
-
RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 12
-
OPENTitle: Perspective: Data sharing for discoveryJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 538Issue #: 7626Start Page: S4End Page: S4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/538s4aBest OA location URL: https://www.nature.com/articles/538S4a.pdfCitation Count: 6
- Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort2022OPENTitle: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00404-wBest OA location URL: https://escholarship.org/content/qt83h7p6sz/qt83h7p6sz.pdfCitation Count: 15